Postoperative instillation of mitomycin C in the treatment of recurrent pterygium.
We examined retrospectively 61 eyes of 61 patients with recurrent pterygia who had been treated with excision, with or without 0.02% mitomycin C instillation, 3 to 7 years after treatment. The rates of recurrence (5% to 9%) and complications in eyes that had undergone excision and mitomycin C instillation were less than those in eyes that had had excision only. These data suggest that the postoperative instillation of 0.02% mitomycin C, twice a day for five days, may be effective and safe in the treatment of recurrent pterygium.
Hayasaka
S
S
Department of Ophthalmology, Shimane Medical University, Izumo, Japan.
Noda
S
S
Yamamoto
Y
Y
Setogawa
T
T
D003229:Conjunctival Diseases; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D011183:Postoperative Complications; D011625:Pterygium / Q000188:drug therapy* / Q000601:surgery; D012008:Recurrence; D012189:Retrospective Studies; D000267:Tissue Adhesions
D008937:Mitomycins; D016685:Mitomycin